GE HealthCare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images - Seite 2
"The integration of Caption AI with the Vscan Air SL handheld ultrasound opens an entirely new chapter for cardiac screening. This technology empowers users with guidance and tools for high quality ultrasound scans and supports earlier detection of cardiac disease," said Roland Rott, president and CEO, Ultrasound, GE HealthCare. "The strategic acquisition of Caption Health in 2023 continues to expand the capabilities of our products and solidifies our leadership in ultrasound and the emerging artificial intelligence landscape."
The launch of Vscan Air SL with Caption AI advances GE HealthCare’s vision and efforts to strengthen precision care, joining the approximately 60 AI-enabled medical device authorizations from GE HealthCare in the United States – more than any other medical device company. Of these, approximately 30 are AI-enabled ultrasound innovations.
In addition to Vscan Air SL, GE HealthCare will also showcase its suite of innovative products and solutions across the cardiology care pathway at ACC 2024, including CardioVisio for Atrial Fibrillation, a digital, patient-centric clinical decision support tool, which includes the most recent ACC guidelines. Telling the story of the heart with integrated cardiology technology, the comprehensive portfolio of cardiovascular solutions delivers across the full continuum of patient care from diagnosis and treatment all the way through post-treatment monitoring.
The Vscan Air SL with Caption AI will be on display in booth #2517. For more information, visit the Vscan Air website here.
About Vscan Air
Lesen Sie auch
GE HealthCare's Vscan Air offers two flexible, wireless, dual-probe handheld ultrasound options: the Vscan Air SL, which includes a sector-phased array transducer for rapid cardiac assessments, and the Vscan Air CL, which includes a curved array transducer for abdominal imaging, obstetric assessments, and more. Uniquely, both models also include a linear array transducer bringing shallow and deep scanning together on a single dual probe device suitable for a wide range of assessments. Both models provide a flexible, lightweight, wireless device that delivers crystal clear images anytime, anywhere to help accelerate diagnoses and treatment decisions. The Vscan Air SL now features Caption AI technology, providing clinicians with real-time, step-by-step guidance for confident cardiac assessments at the point of care. The Vscan Air app, available on Android and iOS devices, allows for the secure viewing of images on a mobile device so clinicians can take Vscan Air with them to every patient.